drugset
drugset / Trial / NCT05547087

A Dose Finding Study of VN-0200

NCT05547087 ↗

Phase 2 Completed 342 enrolled Daiichi Sankyo
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study will assess the immunogenicity, safety and tolerability of VN-0200 after intramuscular injections in Japanese healthy elderly subjects.

Timeline

Start
2022-10-13
Primary completion
2023-04-11
Completion
2024-02-15

Drugs

EvaluationDrugModalityDoseRoute
Subject VN-0200 Vaccine — Intramuscular

Indications

respiratory syncytial virus infectious disease